Gunderson Dettmer has advised Tarsus Pharmaceuticals. Tarsus Pharmaceuticals (Nasdaq: TARS) (“Tarsus”) has announced that it has entered into a securities purchase agreement with qualified institutional buyers…
Tarsus Pharmaceuticals Raises $125 Million in Oversubscribed PIPE Financing
